7Baggers
 can iteos therapeutics inc. stock sustain free cash flow growth  newser.com Mon, 10 Nov 2025 06:25:12 GMT
 published on: 2025-10-31 04:53:16  newser.com Fri, 31 Oct 2025 09:53:16 GMT
 published on: 2025-10-31 04:09:57  newser.com Fri, 31 Oct 2025 09:09:57 GMT
 The 2025 Biotech Graveyard  Fierce Biotech Fri, 31 Oct 2025 07:00:00 GMT

iTeos Therapeutics, Inc
(NASDAQ:ITOS) 

ITOS stock logo

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2a receptor that is an open-label Phase 1/2a...

Founded: 2012
Full Time Employees: 55
CEO: Michel Detheux  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends